Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GC-rich promoter binding protein 1 pseudogene (LOC100131038, ENSG00000248387) is a **pseudogene**, meaning it is a segment of DNA that closely resembles a protein-coding gene but lacks the ability to code for a functional protein due to disabling mutations or lack of necessary regulatory elements[1][3][9]. It shares sequence similarity with the functional gene encoding GC-rich promoter binding protein 1 (GPBP1), which is a DNA-binding transcription factor, but the pseudogene itself is not believed to encode a protein[1][3][9]. Pseudogenes, though traditionally considered "junk DNA," are now understood in some cases to have regulatory potential, such as acting as microRNA decoys or modulators of their protein-coding counterparts, but there is no direct evidence that GC-rich promoter binding protein 1 pseudogene (LOC100131038) carries out such a function specifically[5][7]. This entity is **not considered a therapeutic target**, as it does not produce a protein product and has no established involvement in disease or drug response[1][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GC-rich promoter binding protein 1 pseudogene.